Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Lung Neoplasms 11Breast Neoplasms 10Prostatic Neoplasms 7Colorectal Neoplasms 7Pancreatic Neoplasms 3Ovarian Neoplasms 3Hematopoietic and Lymphatic System Neoplasm 3Hematologic Neoplasms 3Advanced Malignant Solid Neoplasm 3Skin Carcinoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Obesity-Related Malignant Neoplasm 2Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Melanoma 2Malignant Solid Neoplasm 2Lymphoma 2Leukemia, Myeloid, Acute 2Carcinoma, Non-Small-Cell Lung 2Anatomic Stage I Breast Cancer AJCC v8 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Syndrome 1Substance-Related Disorders 1Spondylitis, Ankylosing 1Rectal Neoplasms 1Psoriasis 1Primary Myelofibrosis 1

Interventions

Oxaliplatin 14Leucovorin 12Fluorouracil 12Cetuximab 10Bevacizumab 9pembrolizumab 7Specimen Handling 7Nivolumab 6Magnetic Resonance Spectroscopy 6Irinotecan 5encorafenib 4Pemetrexed 4Gemcitabine 4Cisplatin 4Capecitabine 4fludarabine 3cemiplimab 3Laparoscopy 3Folfox protocol 3Early Intervention, Educational 3Cyclophosphamide 3Carboplatin 3Biopsy 3trifluridine tipiracil drug combination 2pertuzumab 2durvalumab 2dehydroftorafur 2aldesleukin 2X-Rays 2Watchful Waiting 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Neoplasms × Educational Status × 90 days × Clear all
NCT05056077 2026-06-02

TTBF

University of California, San Francisco

Phase NA Active not recruiting
353 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡